Table 2.
ORs (95%CI) | |
---|---|
AD | |
Malignant Melanoma | 0.39 (0.16–0.97) |
Gender | 1.22 (1.07–1.41) |
Race | 1.37 (0.18–10.47) |
Age | 1.12 (1.11–1.14) |
CD | 3.68 (3.19–4.25) |
PVD | 0.74 (0.62–0.88 |
DM | 0.59 (0.08–4.37) |
Basal Cell Carcinoma | 0.18 (0.07–0.45) |
Gender | 1.22 (1.06–1.40) |
Race | 1.43(0.19–10.91) |
Age | 1.12 (1.11–1.14) |
CD | 3.69 (3.19–4.26) |
PVD | 0.74 (0.62–0.88) |
DM | 0.59 (0.08–4.33) |
Squamous Cell Carcinoma | 0.08 (0.01–0.59) |
Gender | 1.22 (1.06–1.40) |
Race | 1.4 (0.18–10.64) |
Age | 1.12 (1.11–1.14) |
CD | 3.68 (3.19–4.26) |
PVD | 0.74 (0.62–0.88) |
DM | 0.60 (0.08–4.38) |